Authors: Drinkard, CR Shatin, D Clouse, J

Citation: Cr. Drinkard et al., Postmarketing surveillance of medications and pregnancy outcomes: Clarithromycin and birth malformations, PHARMA D S, 9(7), 2000, pp. 549-556

Authors: Park, BJ Clouse, J Shatin, D Stergachis, A

Citation: Bj. Park et al., Incidence of adverse oesophageal and gastric events in alendronate users, PHARMA D S, 9(5), 2000, pp. 371-376

Authors: Sullivan, EM Griffiths, RI Frank, RG Strauss, MJ Herbert, RJ Clouse, J Goldman, HH

Citation: Em. Sullivan et al., One-year costs of second-line therapies for depression, J CLIN PSY, 61(4), 2000, pp. 290-298

Authors: Griffiths, RI Sullivan, EM Frank, RG Strauss, MJ Herbert, RJ Clouse, J Goldman, HH

Citation: Ri. Griffiths et al., Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy - Following selective serotonin reuptake inhibitor therapy for depression, PHARMACOECO, 15(5), 1999, pp. 495-505

Authors: Hillman, AL Pauly, MV Escarce, JL Ripley, K Gaynor, M Clouse, J Ross, R

Citation: Al. Hillman et al., Financial incentives and drug spending in managed care, HEAL AFFAIR, 18(2), 1999, pp. 189-200